Pfizer extends offer for Icagen; Maryland readies new biotech funds

@FierceBiotech: Analyst: Benlysta's shortcomings offer blockbuster opening for new lupus drugs. News | Follow @FierceBiotech

@JohnCFierce: Give the big media groups a Ph1/2 cancer drug story success and it spreads like wildfire. Diabetes, etc? Not so much. | Follow @JohnCFierce

@RyanMFierce: Just saw this report about a small EDC player called MedNet Solutions, sort of David and Goliath/Oracle story Story | Follow @RyanMFierce

> Pfizer says it's extending its controversial tender offer for Icagen by 24 hours as it tries to round up a relatively small number of shares needed to complete the transaction. Report

> GeoVax, which is developing HIV vaccines, says the NIH has increased its annual award from $3.6 million to $4.4 million. GeoVax release

> Medimmune president Peter Greenleaf is taking the helm of a new authority which will handle the state of Maryland's investments in tech companies. The state is auctioning off tax breaks and using that money to seed startups. Report

Pharma News

@FiercePharma: Serious infections in AMD patients injected off-label with Avastin. Supports Genentech case that repackaging = risky Report | Follow @FiercePharma

> FTC report IDs new twist on pay-to-delay. Details

> Tarceva's new European OK points up Roche's targeted goals. Article

> Bain, 2 drugmakers still in race for GSK consumer portfolio. Report

Manufacturing News

> Promega adding molecular-biology capacity with new plant. More

> Fareva moves into U.S. with Pfizer plant buy. Story

> Dairy JV nabs India's excipients maker Brahmar. News

> Two CMOs to cut more than 100 jobs in NY, Ireland. Report

> BASF raises excipient, API prices another 10%. Article

> Baxter pumps up lyophilization capacity at Halle plant. Details

Vaccine News

> New strain of H5N1 lacks vax protection. News

> Emory University recieves $26M from NIH. Story

> Infant rotavirus shots may benefit the unvaccinated. Report

> IOM: Vaccines cause very few side effects. Article

> CDC: Teen HPV vaccination rates lagging. Details

And Finally... Researchers say they have created tiny devices that can be implanted in hypoxic tumors to generate oxygen, boosting the killing power of radiation and chemotherapy. Release

Suggested Articles

Omega Therapeutics is working on treatments that adjust gene expression up or down without making permanent changes to the genome.

The IPO window is still wide open for biotech, and French Big Pharma-partnered Innate is looking to jump right on through.

Panelists at the CAR-TCR Summit reflected on gender diversity trends and the challenges women face in the life sciences industry.